mibefradil has been researched along with framycetin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Campillo, NE; Guerra, A; Páez, JA | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Hu, X; Huang, J; Lu, L; Luo, Z; Ye, Z | 1 |
4 other study(ies) available for mibefradil and framycetin
Article | Year |
---|---|
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Electrical stimulation induces calcium-dependent release of NGF from cultured Schwann cells.
Topics: Analysis of Variance; Animals; Animals, Newborn; Biophysics; Botulinum Toxins, Type A; Cadmium Chloride; Caffeine; Calcium; Calcium Channel Blockers; Cells, Cultured; Chelating Agents; Cytochalasins; Dose-Response Relationship, Drug; Egtazic Acid; Electric Stimulation; Enzyme-Linked Immunosorbent Assay; Estrenes; Exocytosis; Mibefradil; Neomycin; Nerve Growth Factor; Nocodazole; Phosphodiesterase Inhibitors; Protein Synthesis Inhibitors; Pyrrolidinones; Rats; Rats, Sprague-Dawley; S100 Proteins; Schwann Cells; Tubulin Modulators | 2010 |